Cost-Effectiveness of HCV Core Antigen versus PCR for Monitoring Treatment Response in DAAS-Treated Egyptian Patients
Afro-Egypt. j. infect. enem. dis
; 10(2): 174-182, 2022. tables, figures
Article
in English
| AIM
| ID: biblio-1426356
Responsible library:
CG1.1
ABSTRACT
PCR is currently the non-debatable proof for diagnosis of HCV infection as well as conclusion of treatment outcomes. HCV core antigen (HCVcAg) testing is a neglected, less expensive and less time consuming test that's presumed to achieve the same aims. The aim of this study is to find the cost-effectiveness of HCV core antigen testing in the monitoring of treatment response as an alternative to the gold-standard PCR test
Full text:
Available
Index:
AIM (Africa)
Main subject:
Seroepidemiologic Studies
/
Environmental Monitoring
Type of study:
Health economic evaluation
Limits:
Humans
Language:
English
Journal:
Afro-Egypt. j. infect. enem. dis
Year:
2022
Type:
Article
Institution/Affiliation country:
Clinical pathology department, Faculty of Medicine/EG
/
Elahrar Teaching Hospital, Zagazig/EG
/
Tropical Medicine department, Faculty of Medicine/EG
Similar
MEDLINE
...
LILACS
LIS